Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Women between 30 and 75 years of age.
- People who have been diagnosed with breast cancer confirmed through a tissue sample test.
- People who are planned to receive a type of chemotherapy that includes drugs called anthracyclines and/or trastuzumab.
- People assessed by their doctor as having a high or very high chance (20% or more) of developing heart-related side effects from chemotherapy.
- People with a general health and activity level rated between 0 and 3 on a standard medical scale (meaning able to carry out at least some self-care, up to fully active).
- People who are able to swallow and take oral (by mouth) study products.
- People who are willing to follow the study procedures and attend follow-up visits.
- People who have given written agreement to participate before any study procedures begin.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People with a general health and activity level rated as 4 on the standard medical scale (meaning completely unable to carry out self-care and confined to bed or chair).
- People with serious pre-existing heart or blood vessel disease that would interfere with taking part in the study.
- People with permanent atrial fibrillation (an irregular heart rhythm) or other significant heart rhythm problems.
- People with severely reduced liver or kidney function.
- People with active tumours or cancer spread to the brain or central nervous system.
- People with high blood pressure that is not under control.
- People with ongoing digestive system conditions that may affect how the body absorbs the study products.
- People with a known allergy or intolerance to grape products or any components of the study products.
- People already taking part in another interventional clinical trial that could affect the results of this study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +77054448869
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Primary endpoints
Change in High-Sensitivity Troponin Levels; Change in NT-proBNP Levels; Change in Left Ventricular Ejection Fraction (LVEF); Change in Global Longitudinal Strain (GLS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.